BTAI vs KMI · rev $388.0K vs P/E 24, rev $9.30B
BioXcel Therapeutics Inc (BTAI) versus Kinder Morgan Inc (KMI) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported KMI revenue for 2026-06-30 was $9.30B. Net income was $1.84B. Revenue was up 92.7% from 2026-03-31 to 2026-06-30. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
BTAI currently screens at market cap $36.1M. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
Not investment advice. Open the BTAI and KMI stock pages for the full models.
Not investment advice.